June 29, 2017 — The U.S. Food and Drug Administration today allowed marketing of ClearLLab Reagents (T1, T2, B1, B2, M), the first agency authorized test for use with flow cytometry to aid in the detection of several leukemias and lymphomas,…Original Article
FDA Allows Marketing of Test to Aid in the Detection of Certain Leukemias and Lymphomas
